share_log

康哲藥業：翌日披露報表

CMS: Next Day Disclosure Return

香港交易所 ·  Apr 11 07:52
Summary by Moomoo AI
康哲藥業控股有限公司（CMS）於2024年4月2日至4月11日期間，進行了多次股份購回活動，但並未註銷這些股份。根據香港聯合交易所有限公司證券上市規則，公司必須披露股本變動情況。在此期間，公司共購回股份數目達8,250,000股，佔已發行股份的0.3365%。最後一次購回發生在2024年4月11日，當日購回1,100,000股，每股價格介於HKD 7.16至HKD 7.34之間，總花費為HKD 7,992,990。購回後，公司於2024年4月11日的已發行股本總數維持在2,451,988,512股。公司秘書吳三燕確認，所有購回活動均獲董事會批准，並符合相關上市規則。
康哲藥業控股有限公司（CMS）於2024年4月2日至4月11日期間，進行了多次股份購回活動，但並未註銷這些股份。根據香港聯合交易所有限公司證券上市規則，公司必須披露股本變動情況。在此期間，公司共購回股份數目達8,250,000股，佔已發行股份的0.3365%。最後一次購回發生在2024年4月11日，當日購回1,100,000股，每股價格介於HKD 7.16至HKD 7.34之間，總花費為HKD 7,992,990。購回後，公司於2024年4月11日的已發行股本總數維持在2,451,988,512股。公司秘書吳三燕確認，所有購回活動均獲董事會批准，並符合相關上市規則。
Conge Pharmaceuticals Holdings Limited (CMS) conducted several share repurchases between April 2 and April 11, 2024, but did not write them off. Under the Listing Rules of the Hong Kong Stock Exchange Limited, companies are required to disclose changes in share capital. During this period, the company repurchased 8,250,000 shares, representing 0.3365% of the issued shares. The last repurchase took place on 11 April 2024 and repurchased 1,100,000 shares at a price of HKD 7.16 to HKD 7.34 for a total cost of HKD 7,992,990. After the repurchase, the company's total issued share capital as of April 11, 2024 remained at 2,451,988,512 shares. Company Secretary Wu Sanyan confirmed that all repurchases have been approved by the Board of Directors and comply with the relevant listing rules.
Conge Pharmaceuticals Holdings Limited (CMS) conducted several share repurchases between April 2 and April 11, 2024, but did not write them off. Under the Listing Rules of the Hong Kong Stock Exchange Limited, companies are required to disclose changes in share capital. During this period, the company repurchased 8,250,000 shares, representing 0.3365% of the issued shares. The last repurchase took place on 11 April 2024 and repurchased 1,100,000 shares at a price of HKD 7.16 to HKD 7.34 for a total cost of HKD 7,992,990. After the repurchase, the company's total issued share capital as of April 11, 2024 remained at 2,451,988,512 shares. Company Secretary Wu Sanyan confirmed that all repurchases have been approved by the Board of Directors and comply with the relevant listing rules.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more